Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J BUON ; 17(2): 377-82, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22740221

RESUMEN

PURPOSE: The purpose of the current experimental research was to investigate whether hydroxyzine can reduce the necrotic area in ischemia-reperfusion injury in epigastric rat skin flaps and to compare its role with cimetidine and vitamin C. METHODS: From a total of 77 ischemic rat skin flaps, 18 were treated with normal saline, 18 with vitamin C, 18 with cimetidine and 18 with hydroxyzine before reperfusion. Flap necrotic area, neutrophils and mast cells were measured on the 7th day. Analysis of variance for multiple comparisons and post hoc Dunnett's test were used for statistical analyses. RESULTS: The sham group of animals (n=5) showed 0% flap necrosis. The saline-treated group demonstrated 75±15.3% of necrosis. The vitamin C, cimetidine and hydroxyzine groups had 56.2 ± 24.4%, 25.8 ± 19.3%, and 33.6 ± 27.8% of flap necrosis, respectively. In addition, the number of neutrophils and mast cells were decreased in the pharmacologically treated groups compared with flaps perfused with normal saline (p<0.05). CONCLUSION: Our data suggest that administering hydroxyzine in rat epigastric skin flaps before reperfusion may attenuate necrosis, neutrophils and mast cell counts. The beneficial effect of cimetidine was the same as hydroxyzine's but the use of vitamin C was less effective.


Asunto(s)
Ácido Ascórbico/administración & dosificación , Cimetidina/administración & dosificación , Hidroxizina/administración & dosificación , Daño por Reperfusión/tratamiento farmacológico , Piel/efectos de los fármacos , Piel/patología , Animales , Femenino , Supervivencia de Injerto , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Antagonistas de los Receptores H2 de la Histamina/administración & dosificación , Inyecciones Intraperitoneales , Mastocitos/efectos de los fármacos , Mastocitos/patología , Necrosis , Neutrófilos/efectos de los fármacos , Neutrófilos/patología , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/patología , Colgajos Quirúrgicos , Vitaminas/administración & dosificación
2.
Eur J Gynaecol Oncol ; 31(2): 201-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20527241

RESUMEN

Pelvic exenteration is the only potentially curative surgical procedure for patients with recurrent cervical, vaginal, vulvar or rectal cancers, especially following adjuvant chemotherapy or radiotherapy. Morbidity rates, however, remain high, which is significantly attributed to complications of the pelvic floor reconstruction techniques. We describe a novel reconstruction technique of the pelvic floor, involving a combination of an oblique rectus abdominis myocutaneous flap and a synthetic absorbable mesh as a pelvic sling for additional support, in a 63-year-old female patient with recurrent vulvar carcinoma. Combining the use of myocutaneous flaps and prosthetic mesh material can provide an effective alternative solution to the complications arising from pelvic floor reconstruction of large defects after exenteration procedures, especially in previously irradiated settings. Further studies are necessary to define the long-term outcomes and indications of these techniques, as well as the optimal combination between the available myocutaneous flaps and prosthetic materials.


Asunto(s)
Carcinoma/cirugía , Exenteración Pélvica/métodos , Procedimientos de Cirugía Plástica/métodos , Neoplasias de la Vulva/cirugía , Femenino , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia/cirugía , Pelvis/cirugía , Implantación de Prótesis/métodos , Cabestrillo Suburetral , Colgajos Quirúrgicos , Mallas Quirúrgicas
3.
Plast Reconstr Surg ; 105(2): 654-9, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10697173

RESUMEN

The objective of this study was to examine the role of mast cells and their principal product, histamine, in ischemia/reperfusion injury. Cromolyn sodium, diphenhydramine, and cimetidine were administered to ischemic flaps just before reperfusion and evaluated for flap survival, mast cell count, neutrophil count, and myeloperoxidase levels. Epigastric island skin flaps were elevated in 49 rats; they were rendered ischemic by clamping the artery for 10 hours. Thirty minutes before reperfusion, the rats were treated with intraperitoneal saline (n = 11), cimetidine (n = 11), diphenhydramine (n = 11), or cromolyn sodium (n = 10). Flap survival was evaluated at 7 days. Neutrophil counts, mast cell counts, and myeloperoxidase levels were evaluated 12 hours after reperfusion. Flap necrosis in the sham group of animals (n = 6) was 0.0 percent, as expected, whereas the control group (saline-treated animals) had 47.3+/-33.4 percent necrosis. Animals treated with diphenhydramine and cimetidine demonstrated a significant decrease in flap necrosis to 17.7+/-8.8 percent and 19.4+/-14.7 percent, respectively. This protective effect was not seen with cromolyn sodium (44.3+/-35.6 percent). Both neutrophil and mast cell counts were significantly decreased in flaps from antihistamine-treated and sham animals versus both saline- and cromolyn sodium-treated groups. The administration of diphenhydramine and cimetidine before reperfusion can significantly reduce the extent of flap necrosis and the neutrophil and mast cell counts caused by ischemia/reperfusion. This protective effect is not seen with cromolyn sodium. The protective effect of antihistamines on flap necrosis might be related to the decrease in neutrophils and, possibly, mast cells within the flap.


Asunto(s)
Mastocitos/fisiología , Daño por Reperfusión/prevención & control , Colgajos Quirúrgicos/irrigación sanguínea , Animales , Recuento de Células , Cimetidina/farmacología , Cromolin Sódico , Difenhidramina/farmacología , Femenino , Antagonistas de los Receptores Histamínicos/farmacología , Neutrófilos , Ratas , Ratas Sprague-Dawley
4.
5.
J Clin Oncol ; 16(6): 2261-6, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9626229

RESUMEN

PURPOSE: Resection of solitary metastases from renal cell carcinoma (RCC) is associated with a 5-year survival rate of 35% to 50%. Selection criteria are not well defined. PATIENTS AND METHODS: We retrospectively analyzed our experience with 278 patients with recurrent RCC from 1980 to 1993. RESULTS: One hundred forty-one of 278 patients underwent a curative metastectomy for their first recurrence (44% 5-year overall survival [OS] rate), 70 patients underwent noncurative surgery (14% 5-year OS rate), and 67 patients were treated nonsurgically (11% 5-year OS rate). Favorable features for survival were a disease-free interval (DFI) greater than 12 months versus 12 months or less (55% v 9% 5-year OS rate; P < .0001), solitary versus multiple sites of metastases (54% v 29% 5-year OS rate; P < .001), and age younger than 60 years (49% v 35% 5-year OS rate; P < .05). Among 94 patients with a solitary metastasis, lung (n = 50; 54% 5-year OS rate) was more favorable than brain (n = 11; 18% 5-year OS rate; P < .05). Survival rates after curative resection of second and third metastases were not different compared with initial metastectomy (46% and 44%, respectively, v 43% 5-year OS rates; P = nonsignificant). Favorable predictors of survival by multivariate analysis included a single site of first recurrence, curative resection of first metastasis, a long DFI, a solitary site of first metastasis, and a metachronous presentation with recurrence. CONCLUSION: Selected patients with recurrent RCC who can undergo a curative resection of their disease have a good opportunity for long-term survival, particularly those with a single site of recurrence and/or a long DFI.


Asunto(s)
Carcinoma de Células Renales/secundario , Metástasis de la Neoplasia/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Renales/epidemiología , Carcinoma de Células Renales/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia
6.
Plast Reconstr Surg ; 100(5): 1227-33, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9326784

RESUMEN

The objective of this study was to examine whether the administration of L-arginine, a precursor of nitric oxide and substrate of nitric oxide synthase, prior to reperfusion could lead to decrease in neutrophil-mediated tissue injury and improved flap survival. Epigastric island skin flaps were elevated in 70 rats and rendered ischemic. Thirty minutes prior to reperfusion, the rats were treated with intraperitoneal saline (n = 15), L-arginine (n = 15), D-arginine (n = 15), or N omega-nitro-L-arginine methylester plus L-arginine in equimolar amounts (n = 15). Flap survival at 7 days and neutrophil counts at 24 hours were evaluated. Flap necrosis as expected in the sham group of animals (n = 10) was 0.0 percent, while the control (saline-treated) animals had 59.6 percent necrosis. Animals treated with L-arginine demonstrated a significant decrease in flap necrosis to 12.7 percent. This protective effect was almost completely negated by N omega-nitrol-L-arginine methylester, which significantly increased flap necrosis to 49.3 percent and was much less pronounced with D-arginine (28.6 percent). Neutrophil counts were significantly decreased in flaps from L-arginine-treated and sham animals versus both saline and N omega-nitro-L-arginine methylester-treated groups. We conclude that administration of L-arginine prior to reperfusion can significantly reduce the extent of flap necrosis and flap neutrophil counts due to ischemia-reperfusion injury. This protective effect is completely negated by nitric oxide synthase inhibition. Since L-arginine reduces the number of neutrophils within the flap and the extent of flap necrosis only in the presence of active nitric oxide synthase, we hypothesize that this protective effect of L-arginine on ischemia-reperfusion injury is secondary to a nitric oxide-mediated suppression of neutrophil-mediated injury.


Asunto(s)
Arginina/uso terapéutico , Daño por Reperfusión/prevención & control , Colgajos Quirúrgicos/irrigación sanguínea , Animales , Femenino , Supervivencia de Injerto , NG-Nitroarginina Metil Éster/farmacología , Necrosis , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/patología , Colgajos Quirúrgicos/patología
7.
Plast Reconstr Surg ; 98(2): 354-7, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8764727

RESUMEN

Wide resection of parastomal tissues after stomal recurrence significantly benefits patient survival. The defect thus created often requires coverage with a flap that provides (1) well-vascularized skin and soft tissue for uncomplicated wound closure and (2) pliable skin that can be inset easily around the often-shortened tracheal remnant. The radial forearm fasciocutaneous flap is ideal for these types of reconstructive problems. It should therefore be included on the reconstructive ladder for tracheostomy reconstruction both as a first choice and as a backup flap.


Asunto(s)
Carcinoma de Células Escamosas/secundario , Carcinoma de Células Escamosas/cirugía , Colgajos Quirúrgicos/métodos , Neoplasias de la Tráquea/secundario , Neoplasias de la Tráquea/cirugía , Traqueostomía , Anciano , Humanos , Neoplasias Laríngeas/cirugía , Laringectomía , Masculino
8.
Br J Plast Surg ; 47(8): 560-2, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7697284

RESUMEN

Between 1984 and 1992, 300 patients underwent breast reduction in our unit. Three patients during the follow-up period were found to have a palpable mass in their breast. Excision biopsy revealed fat necrosis of the breast. The clinical, radiological and pathological features of fat necrosis of the breast are described.


Asunto(s)
Mama/patología , Necrosis Grasa/etiología , Mamoplastia/efectos adversos , Adolescente , Adulto , Neoplasias de la Mama/diagnóstico , Diagnóstico Diferencial , Necrosis Grasa/diagnóstico , Femenino , Humanos , Mamografía , Persona de Mediana Edad , Ultrasonografía Mamaria
9.
Ann Plast Surg ; 28(2): 167-74, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1567119

RESUMEN

Large decubitus ulcers can be treated by using many methods, including musculocutaneous flaps. Musculocutaneous flaps provide reliable, well-vascularized cover and often can be revised in patients with secondary recurrence. We have treated 30 patients with large decubitus ulcers during a 5-year period by using musculocutaneous advancement flaps of the gluteus maximus, the hamstring muscle, and the tensor fasciae latae. There were two complications treated by debridement with flap advancement in 1 patient and the use of another flap in the second patient. Four patients developed a recurrent ulcer, which was treated by reelevation and advancement of the original flap in all patients. The general management and overall results are presented.


Asunto(s)
Úlcera de la Pierna/cirugía , Músculos/trasplante , Úlcera por Presión/cirugía , Trasplante de Piel/métodos , Colgajos Quirúrgicos , Transferencia Tendinosa/métodos , Nalgas , Fascia Lata , Cadera , Humanos , Rodilla , Úlcera de la Pierna/etiología , Región Lumbosacra , Úlcera por Presión/etiología , Cicatrización de Heridas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA